What question did this study set out to answer?

The research aims to explore the role of SETD2 in tumor metabolism and its impact on immunotherapy outcomes across various cancer types.

Novel roles of SETD2 in tumor metabolism and immunotherapy: a systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Systematic review identifies SETD2's influence on tumor metabolism and immunotherapy response, suggesting new therapeutic strategies.

The research aims to explore the role of SETD2 in tumor metabolism and its impact on immunotherapy outcomes across various cancer types.
Systematic search of multiple databases following PRISMA guidelines
Inclusion of studies on SETD2's role in tumor metabolism and immunotherapy
Meta-analysis using random-effects models to evaluate SETD2 status and clinical outcomes
SETD2 loss linked to metabolic reprogramming (pooled OR: 2.34)
Decreased immunotherapy response associated with SETD2 loss (HR: 1.56)
Mechanistic insights showed SETD2 deficiency led to glycolytic shift and increased regulatory T cells

Liu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark